These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2543991)

  • 1. Conditioned stereotypy: behavioral specification of the UCS and pharmacological investigation of the neural change.
    Hiroi N; White NM
    Pharmacol Biochem Behav; 1989 Jan; 32(1):249-58. PubMed ID: 2543991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
    Cheal M; Kurkulos ME; Silva L
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.
    Dewey KJ; Fibiger HC
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):261-70. PubMed ID: 6683359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the difference in the behavioral effects of apomorphine in C57BL/6 and DBA/2 mice.
    Vetulani J; Sansone M; Oliverio A
    Pharmacol Biochem Behav; 1982 Nov; 17(5):967-71. PubMed ID: 6891071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPA glutamate receptor activation in the posterior zona incerta inhibits amphetamine- and apomorphine-induced stereotypy.
    Supko DE; Wallace LJ
    Brain Res; 1992 Jul; 584(1-2):213-8. PubMed ID: 1381265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fasting on the stereotyped behaviour induced by amphetamine and by apomorphine in the albino rat.
    Fuenmayor LD; Diaz S
    Eur J Pharmacol; 1984 Mar; 99(2-3):153-8. PubMed ID: 6539708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evidence for the subclassification of central dopamine receptors in the rat.
    Gower AJ; Marriott AS
    Br J Pharmacol; 1982 Sep; 77(1):185-93. PubMed ID: 6889902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioning of pre- and post-synaptic behavioural responses to the dopamine receptor agonist apomorphine in rats.
    Möller HG; Nowak K; Kuschinsky K
    Psychopharmacology (Berl); 1987; 91(1):50-5. PubMed ID: 3029794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of amphetamine-stereotypy by mesostriatal dopamine depletion enhances plasma corticosterone: implications for stereotypy as a coping response.
    Jones GH; Mittleman G; Robbins TW
    Behav Neural Biol; 1989 Jan; 51(1):80-91. PubMed ID: 2705984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment.
    Rebec GV; Segal DS
    Pharmacol Biochem Behav; 1980 Dec; 13(6):793-7. PubMed ID: 7193874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of Wistar rats: a genuine model of basal ganglia dysfunction?
    Turski L; Schwarz M; Sontag KH
    Behav Brain Res; 1984 Apr; 12(1):29-37. PubMed ID: 6539616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of amphetamine and apomorphine after striatal lesions in the rat.
    Antoniou K; Kafetzopoulos E
    Pharmacol Biochem Behav; 1992 Nov; 43(3):705-22. PubMed ID: 1448467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioned response to apomorphine in nigro-striatal system-lesioned rats: the origin of undrugged rotational response.
    Burunat E; Castro R; Diaz-Palarea MD; Rodriguez M
    Life Sci; 1987 Oct; 41(15):1861-6. PubMed ID: 3657388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPA/kainic acid glutamate receptor antagonism in the zona incerta dorsal to the subthalamic nucleus inhibits amphetamine-induced stereotypy bur not locomotor activity.
    Supko DE; Uretsky NJ; Wallace LJ
    Brain Res; 1992 Mar; 576(1):89-96. PubMed ID: 1325238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
    Timar J; Knoll B; Knoll J
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):255-66. PubMed ID: 3103558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.